Type
IAL--sponsored workshop on "Advances in laboratory techniques with reference to patient care in leprosy", Drug-Bhilai. Jan. 5th 1992. Indian journal of leprosy. 1992;64(3):413-5.
Type
. Child sponsorship programme to prevent dehabilitation. Indian journal of leprosy. 1992;64(3):395-6.
Type
. Duration of MDT for paucibacillary leprosy. Indian journal of leprosy. 1992;64(3):391-3; author reply 393-4.
Type
. Leprosy in Albania. Indian journal of leprosy. 1992;64(3):385-8.
Type
. Phenobarbitone in the treatment of dapsone induced hyperbilirubinaemia. Indian journal of leprosy. 1992;64(3):381-4.
Type
. Pattern of leprosy deformities among agricultural labourers in an endemic district: a pilot study. Indian journal of leprosy. 1992;64(3):375-9.
Type
. Leprosy immunopathogenesis and vaccine development. Indian journal of leprosy. 1992;64(3):359-74.
Type
. A project model for attempting integration of leprosy services with general health care services after the prevalence of the disease is reduced in the endemic districts on multidrug therapy for over five years. Indian journal of leprosy. 1992;64(3):349-57.
Type
. A comparative KAP study of leprosy patients and members of the community in Hlaing and Laung-Lon townships. Indian journal of leprosy. 1992;64(3):313-24.
Type
. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide. Indian journal of leprosy. 1992;64(3):303-12.